Alvogen And Natco Facing Decade Wait On Ibrutinib After US Appeal Fails

Delaware District Court Had Previously Rejected Four Patent Challenges

 
• By Dean Rudge
  
Prohibited_Stamp
Alvogen's challenge included to the molecule patent • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin